Covered recipient · General Payments record
PENNY M GARZA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,191.64
- Reported across 69 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $336.91 | 21 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $99.97 | 6 |
| ABBVIE INC. | $83.98 | 5 |
| Amgen Inc. | $41.96 | 3 |
| Acerta Pharma LLC | $34.81 | 2 |
| Exact Sciences Corporation | $17.86 | 1 |
| Merck Sharp & Dohme Corporation | $17.36 | 1 |
| Teva Pharmaceuticals USA, Inc. | $14.30 | 1 |
| Otsuka America Pharmaceutical, Inc. | $13.55 | 1 |
| Lilly USA, LLC | $13.12 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (21)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.82 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107155116 | CMS |
| ABBVIE INC. | $14.46 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107155118 | CMS |
| ABBVIE INC. | $20.98 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107155120 | CMS |
| ABBVIE INC. | $15.33 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107155122 | CMS |
| ABBVIE INC. | $15.39 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107155124 | CMS |
| Amgen Inc. | $14.03 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117560374 | CMS |
| Amgen Inc. | $13.44 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117560376 | CMS |
| Amgen Inc. | $14.49 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117560378 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.44 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105698580 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.37 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104557762 | CMS |
| Exact Sciences Corporation | $17.86 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114517534 | CMS |
| Lilly USA, LLC | $13.12 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135878080 | CMS |
| Merck Sharp & Dohme LLC | $17.36 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141953421 | CMS |
| Novo Nordisk Inc | $17.31 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100497403 | CMS |
| Novo Nordisk Inc | $13.53 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100645847 | CMS |
| Novo Nordisk Inc | $21.99 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100555625 | CMS |
| Novo Nordisk Inc | $16.00 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100255084 | CMS |
| Novo Nordisk Inc | $14.76 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100254492 | CMS |
| Novo Nordisk Inc | $16.38 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100599515 | CMS |
| Otsuka America Pharmaceutical, Inc. | $13.55 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119077596 | CMS |
| Teva Pharmaceuticals USA, Inc. | $14.30 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151739982 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.